Shut Down

3Scan Stock

3Scan offers automated microscopy services and supporting software for the 3D analysis of cells, tissues, and organs.

Sign up today and learn more about 3Scan Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About 3Scan Stock

3Scan is turning tissue into bits by building robotic microscopy tools and software for large-scale sample analysis and 3D visualizations. Many diseases emerge only at a tissue level, such as cancer, heart disease, lung disease, stroke, Alzheimer's, and diabetes. 3Scan enables higher throughput, greater quantification, and broader image analysis than what is currently possible with traditional histopathology. 3Scan's data-driven approach is expanding our understanding of tissue biology and will lead to the discovery of new diagnostics and therapeutics.

Funding History

August 2011$40K
April 2012$350K
July 2013$0
December 2014$6.7M
July 2016$14.0M


Business Development Lead

Devan Shah

Master Chief Engineer

Cody Daniel


Megan Klimen

Director of Production

Gerald Spencer


Matthew Goodman


Todd Huffman

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: